111 related articles for article (PubMed ID: 29454591)
1. The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.
Fletcher SA; Gild P; Cole AP; Vetterlein MW; Kibel AS; Choueiri TK; Sonpavde GP; Preston MA; Pucheril D; Menon M; Sun M; Lipsitz SR; Trinh QD
Urol Oncol; 2018 May; 36(5):238.e7-238.e17. PubMed ID: 29454591
[TBL] [Abstract][Full Text] [Related]
2. Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals.
Krimphove MJ; Fletcher SA; Cole AP; Berg S; Sun M; Lipsitz SR; Mahal BA; Nguyen PL; Choueiri TK; Kibel AS; Kluth LA; Weissman JS; Trinh QD
J Urol; 2019 Apr; 201(4):735-741. PubMed ID: 30414956
[TBL] [Abstract][Full Text] [Related]
3. Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States.
Cole AP; Nguyen DD; Meirkhanov A; Golshan M; Melnitchouk N; Lipsitz SR; Kilbridge KL; Kibel AS; Cooper Z; Weissman J; Trinh QD
JAMA Netw Open; 2019 Feb; 2(2):e187633. PubMed ID: 30707230
[TBL] [Abstract][Full Text] [Related]
4. Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations.
Nguyen DD; Labban M; Briggs L; Wallis CJD; Cole AP; Lipsitz SR; Iyer HS; Rebbeck TR; Weissman JS; Choueiri TK; Trinh QD
Urol Oncol; 2023 May; 41(5):252.e9-252.e17. PubMed ID: 36759298
[TBL] [Abstract][Full Text] [Related]
5. Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer.
Nguyen DD; Paciotti M; Marchese M; Cole AP; Cone EB; Kibel AS; Ortega G; Lipsitz SR; Weissman JS; Trinh QD
JCO Oncol Pract; 2021 May; 17(5):e654-e665. PubMed ID: 33974827
[TBL] [Abstract][Full Text] [Related]
6. Disparities in NCCN Guideline Compliant Care for Resectable Cholangiocarcinoma at Minority-Serving Versus Non-Minority-Serving Hospitals.
Tsilimigras DI; Dalmacy D; Hyer JM; Diaz A; Abbas A; Pawlik TM
Ann Surg Oncol; 2021 Dec; 28(13):8162-8171. PubMed ID: 34036428
[TBL] [Abstract][Full Text] [Related]
7. Racial Disparities in Treatment for Rectal Cancer at Minority-Serving Hospitals.
Lu PW; Scully RE; Fields AC; Welten VM; Lipsitz SR; Trinh QD; Haider A; Weissman JS; Freund KM; Melnitchouk N
J Gastrointest Surg; 2021 Jul; 25(7):1847-1856. PubMed ID: 32725520
[TBL] [Abstract][Full Text] [Related]
8. Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals.
Deboever N; Correa AM; Feldman H; Mathur U; Hofstetter WL; Mehran RJ; Rice DC; Roth JA; Sepesi B; Swisher SG; Walsh GL; Vaporciyan AA; Antonoff MB; Rajaram R
J Thorac Cardiovasc Surg; 2024 Jan; 167(1):329-337.e4. PubMed ID: 37116780
[TBL] [Abstract][Full Text] [Related]
9. Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013).
Weiner AB; Keeter MK; Manjunath A; Meeks JJ
Urol Oncol; 2018 May; 36(5):237.e9-237.e17. PubMed ID: 29338913
[TBL] [Abstract][Full Text] [Related]
10. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.
Gray PJ; Fedewa SA; Shipley WU; Efstathiou JA; Lin CC; Zietman AL; Virgo KS
Eur Urol; 2013 May; 63(5):823-9. PubMed ID: 23200811
[TBL] [Abstract][Full Text] [Related]
11. Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving versus Non-Minority-Serving Hospitals.
Lima HA; Alaimo L; Moazzam Z; Endo Y; Woldesenbet S; Katayama E; Munir MM; Shaikh C; Ruff SM; Dillhoff M; Beane J; Cloyd J; Ejaz A; Resende V; Pawlik TM
Ann Surg Oncol; 2023 Jul; 30(7):4363-4372. PubMed ID: 36800128
[TBL] [Abstract][Full Text] [Related]
12. Sex and Racial Disparities in the Treatment and Outcomes of Muscle-invasive Bladder Cancer.
Marinaro J; Zeymo A; Egan J; Carvalho F; Krasnow R; Stamatakis L; Lynch J; Hwang J; Williams S; Kowalczyk K
Urology; 2021 May; 151():154-162. PubMed ID: 32810481
[TBL] [Abstract][Full Text] [Related]
13. Medicare's Hospital Acquired Condition Reduction Program Disproportionately Affects Minority-serving Hospitals: Variation by Race, Socioeconomic Status, and Disproportionate Share Hospital Payment Receipt.
Zogg CK; Thumma JR; Ryan AM; Dimick JB
Ann Surg; 2020 Jun; 271(6):985-993. PubMed ID: 31469746
[TBL] [Abstract][Full Text] [Related]
14. Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer.
Klapheke A; Yap SA; Pan K; Cress RD
Urol Oncol; 2018 Jun; 36(6):308.e19-308.e25. PubMed ID: 29628318
[TBL] [Abstract][Full Text] [Related]
15. Disparities in Surgical Treatment of Resectable Pancreatic Adenocarcinoma at Minority Serving Hospitals.
Olecki EJ; Perez Holguin RA; Mayhew MM; Wong WG; Vining CC; Peng JS; Shen C; Dixon MEB
J Surg Res; 2024 Feb; 294():160-168. PubMed ID: 37897875
[TBL] [Abstract][Full Text] [Related]
16. Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer.
Washington SL; Neuhaus J; Meng MV; Porten SP
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1339-1344. PubMed ID: 31092404
[TBL] [Abstract][Full Text] [Related]
17. Temporal Trends in Critical Care Outcomes in U.S. Minority-Serving Hospitals.
Danziger J; Ángel Armengol de la Hoz M; Li W; Komorowski M; Deliberato RO; Rush BNM; Mukamal KJ; Celi L; Badawi O
Am J Respir Crit Care Med; 2020 Mar; 201(6):681-687. PubMed ID: 31948262
[No Abstract] [Full Text] [Related]
18. Treatment in Disproportionately Minority Hospitals Is Associated With Increased Risk of Mortality in Sepsis: A National Analysis.
Rush B; Danziger J; Walley KR; Kumar A; Celi LA
Crit Care Med; 2020 Jul; 48(7):962-967. PubMed ID: 32345833
[TBL] [Abstract][Full Text] [Related]
19. Lower use of carotid artery imaging at minority-serving hospitals.
Cheng EM; Keyhani S; Ofner S; Williams LS; Hebert PL; Ordin DL; Bravata DM
Neurology; 2012 Jul; 79(2):138-44. PubMed ID: 22700815
[TBL] [Abstract][Full Text] [Related]
20. Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.
Sung JM; Martin JW; Jefferson FA; Sidhom DA; Piranviseh K; Huang M; Nguyen N; Chang J; Ziogas A; Anton-Culver H; Youssef RF
Clin Genitourin Cancer; 2019 Oct; 17(5):e995-e1002. PubMed ID: 31239240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
